Related News
‘Venom’ boosts Chinese box office as hopes rise for sustained market heat
Print Edition
I never thought Venom was anything more than a villain, but this film moved me to tears,” one Weibo user remarked, reflecting on the unexpectedly strong response to “Venom: The Last Dance.”
The latest installment in Sony’s “Venom” franchise debuted in China on October 23 during what is typically a quiet period for China’s box office — between the National Day holiday in early October and the year-end moviegoing period, which begins in late November.
However, Sony Pictures took to Chinese social media to celebrate the film’s success, highlighting its impressive five-day run at the top of China’s daily box office — a rare feat for Hollywood releases in recent years.
Ticketing platform Maoyan projects the film to end its China box-office run with more than 580 million yuan (US$81 million) in earnings.
While the influence of Hollywood films has generally waned in China compared with a decade ago, the success of “Venom” suggests certain US franchise titles can still capture a diverse range of viewers.
This can also be seen in the mixed reception other recent Hollywood releases have received in China. “Joker: Folie à Deux,” which premiered on October 16, hasn’t matched the box-office impact of its 2019 predecessor but has nevertheless found an audience in fans of more complex narratives. While some viewers have found the sequel’s introspective tone to be a departure from the first installment, others have lauded it as a bold, deconstructed take on the Joker mythos.
The real test now is whether “Venom” can sustain its momentum through the schedule of upcoming releases.
Dong Wenxin, a film critic and cinema manager, has noted the surprising strength of the post-holiday period, which is often considered a cold season for the box office.
“Is this truly a cold season?” Dong asked, noting that strong releases can keep theaters busy even in typically quiet months.
She expressed hope that “Cesium Fallout,” a disaster film which stars Hong Kong veteran actor Andy Lau and was released yesterday, could be a candidate to sustain the market heat following “Venom.”
Hollywood’s broader performance in China this year has been mixed, with “Godzilla x Kong: The New Empire” and “Alien: Romulus” currently standing as the only two US films in the annual top 12, grossing close to 960 million and 790 million yuan, respectively.
Industry watchers are now setting their sights on the year-end moviegoing period, which begins on November 22, with Dwayne Johnson’s “Red One” scheduled to arrive in theaters next Friday.
Johnson’s name recognition in China, cemented by his role in the “Fast & Furious” film series, has generated widespread anticipation for “Red One.” “Fast & Furious Presents: Hobbs & Shaw,” the last installment in the blockbuster franchise to feature the US actor, earned 1.4 billion yuan in China in 2019.
Despite no longer being a guaranteed box-office draw, Hollywood titles still provide the variety that keeps China’s theatrical landscape dynamic. As 2024 enters its final quarter, industry insiders are cautiously optimistic that a well-curated slate can maintain momentum, offering a promising close to the year.
China’s 2024 box office has topped 38 billion yuan — a 22 percent drop year on year, underscoring the high stakes for Hollywood and domestic releases alike in the months ahead.
Here are some productions to be released on the Chinese mainland in November.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
